From Argentum: A Status Update on COVID-19 Vaccine

From Argentum: A Status Update on COVID-19 Vaccine

In an article written by Argentum, which was based on information from the American College of Medical Toxicology (ACMT) webinar, “Update on COVID-19 Vaccine Clinical Trials: Are We There Yet?,” from October 28, 2020, Argentum shares a status update on two COVID-19 vaccines currently in clinical trials.

The article states that The Trump Administration's Operation Warp Speed established a goal of developing a COVID-19 vaccine within 14 months, rather than the typical six-year timeframe that it takes to develop most vaccines. The goal is to have a safe and effective vaccine by January 1, 2021.

Click Here to read the article and learn the status of the vaccines developed by Pfizer and Moderna, both of which are in Phase III of clinical trials.